Global Precision Oncology Market Research Report 2023

Precision Oncology Market

Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Precision Oncology market research.

Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Precision Oncology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Precision Oncology Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Precision Oncology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Diagnostics

1.2.3 Therapeutics

1.3 Market by Application

1.3.1 Global Precision Oncology Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Pharmaceutical & Biotechnology Companies

1.3.3 Hospitals & Diagnostic Laboratories

1.3.4 Healthcare Data Companies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Precision Oncology Market Perspective (2018-2029)

2.2 Precision Oncology Growth Trends by Region

2.2.1 Global Precision Oncology Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Precision Oncology Historic Market Size by Region (2018-2023)

2.2.3 Precision Oncology Forecasted Market Size by Region (2024-2029)

2.3 Precision Oncology Market Dynamics

2.3.1 Precision Oncology Industry Trends

2.3.2 Precision Oncology Market Drivers

2.3.3 Precision Oncology Market Challenges

2.3.4 Precision Oncology Market Restraints

3.1 Global Top Precision Oncology Players by Revenue

3.1.1 Global Top Precision Oncology Players by Revenue (2018-2023)

3.1.2 Global Precision Oncology Revenue Market Share by Players (2018-2023)

3.2 Global Precision Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Precision Oncology Revenue

3.4 Global Precision Oncology Market Concentration Ratio

3.4.1 Global Precision Oncology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Precision Oncology Revenue in 2022

3.5 Precision Oncology Key Players Head office and Area Served

3.6 Key Players Precision Oncology Product Solution and Service

3.7 Date of Enter into Precision Oncology Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Precision Oncology Historic Market Size by Type (2018-2023)

4.2 Global Precision Oncology Forecasted Market Size by Type (2024-2029)

5.1 Global Precision Oncology Historic Market Size by Application (2018-2023)

5.2 Global Precision Oncology Forecasted Market Size by Application (2024-2029)

6.1 North America Precision Oncology Market Size (2018-2029)

6.2 North America Precision Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Precision Oncology Market Size by Country (2018-2023)

6.4 North America Precision Oncology Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Precision Oncology Market Size (2018-2029)

7.2 Europe Precision Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Precision Oncology Market Size by Country (2018-2023)

7.4 Europe Precision Oncology Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Precision Oncology Market Size (2018-2029)

8.2 Asia-Pacific Precision Oncology Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Precision Oncology Market Size by Region (2018-2023)

8.4 Asia-Pacific Precision Oncology Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Precision Oncology Market Size (2018-2029)

9.2 Latin America Precision Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Precision Oncology Market Size by Country (2018-2023)

9.4 Latin America Precision Oncology Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Precision Oncology Market Size (2018-2029)

10.2 Middle East & Africa Precision Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Precision Oncology Market Size by Country (2018-2023)

10.4 Middle East & Africa Precision Oncology Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Acrivon Therapeutics

11.1.1 Acrivon Therapeutics Company Detail

11.1.2 Acrivon Therapeutics Business Overview

11.1.3 Acrivon Therapeutics Precision Oncology Introduction

11.1.4 Acrivon Therapeutics Revenue in Precision Oncology Business (2018-2023)

11.1.5 Acrivon Therapeutics Recent Development

11.2 Bio-Serv

11.2.1 Bio-Serv Company Detail

11.2.2 Bio-Serv Business Overview

11.2.3 Bio-Serv Precision Oncology Introduction

11.2.4 Bio-Serv Revenue in Precision Oncology Business (2018-2023)

11.2.5 Bio-Serv Recent Development

11.3 Exact Sciences Corporation

11.3.1 Exact Sciences Corporation Company Detail

11.3.2 Exact Sciences Corporation Business Overview

11.3.3 Exact Sciences Corporation Precision Oncology Introduction

11.3.4 Exact Sciences Corporation Revenue in Precision Oncology Business (2018-2023)

11.3.5 Exact Sciences Corporation Recent Development

11.4 Illumina, Inc.

11.4.1 Illumina, Inc. Company Detail

11.4.2 Illumina, Inc. Business Overview

11.4.3 Illumina, Inc. Precision Oncology Introduction

11.4.4 Illumina, Inc. Revenue in Precision Oncology Business (2018-2023)

11.4.5 Illumina, Inc. Recent Development

11.5 Invitae Corporation

11.5.1 Invitae Corporation Company Detail

11.5.2 Invitae Corporation Business Overview

11.5.3 Invitae Corporation Precision Oncology Introduction

11.5.4 Invitae Corporation Revenue in Precision Oncology Business (2018-2023)

11.5.5 Invitae Corporation Recent Development

11.6 Laboratory Corporation of America

11.6.1 Laboratory Corporation of America Company Detail

11.6.2 Laboratory Corporation of America Business Overview

11.6.3 Laboratory Corporation of America Precision Oncology Introduction

11.6.4 Laboratory Corporation of America Revenue in Precision Oncology Business (2018-2023)

11.6.5 Laboratory Corporation of America Recent Development

11.7 QIAGEN

11.7.1 QIAGEN Company Detail

11.7.2 QIAGEN Business Overview

11.7.3 QIAGEN Precision Oncology Introduction

11.7.4 QIAGEN Revenue in Precision Oncology Business (2018-2023)

11.7.5 QIAGEN Recent Development

11.8 Rain Oncology

11.8.1 Rain Oncology Company Detail

11.8.2 Rain Oncology Business Overview

11.8.3 Rain Oncology Precision Oncology Introduction

11.8.4 Rain Oncology Revenue in Precision Oncology Business (2018-2023)

11.8.5 Rain Oncology Recent Development

11.9 Relay Therapeutics

11.9.1 Relay Therapeutics Company Detail

11.9.2 Relay Therapeutics Business Overview

11.9.3 Relay Therapeutics Precision Oncology Introduction

11.9.4 Relay Therapeutics Revenue in Precision Oncology Business (2018-2023)

11.9.5 Relay Therapeutics Recent Development

11.10 Strata Oncology, Inc.

11.10.1 Strata Oncology, Inc. Company Detail

11.10.2 Strata Oncology, Inc. Business Overview

11.10.3 Strata Oncology, Inc. Precision Oncology Introduction

11.10.4 Strata Oncology, Inc. Revenue in Precision Oncology Business (2018-2023)

11.10.5 Strata Oncology, Inc. Recent Development

11.11 Thermo Fisher Scientific Inc.

11.11.1 Thermo Fisher Scientific Inc. Company Detail

11.11.2 Thermo Fisher Scientific Inc. Business Overview

11.11.3 Thermo Fisher Scientific Inc. Precision Oncology Introduction

11.11.4 Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2018-2023)

11.11.5 Thermo Fisher Scientific Inc. Recent Development

11.12 Variantyx, Inc.

11.12.1 Variantyx, Inc. Company Detail

11.12.2 Variantyx, Inc. Business Overview

11.12.3 Variantyx, Inc. Precision Oncology Introduction

11.12.4 Variantyx, Inc. Revenue in Precision Oncology Business (2018-2023)

11.12.5 Variantyx, Inc. Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Precision Oncology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Diagnostics

    Table 3. Key Players of Therapeutics

    Table 4. Global Precision Oncology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Precision Oncology Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Precision Oncology Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Precision Oncology Market Share by Region (2018-2023)

    Table 8. Global Precision Oncology Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Precision Oncology Market Share by Region (2024-2029)

    Table 10. Precision Oncology Market Trends

    Table 11. Precision Oncology Market Drivers

    Table 12. Precision Oncology Market Challenges

    Table 13. Precision Oncology Market Restraints

    Table 14. Global Precision Oncology Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Precision Oncology Market Share by Players (2018-2023)

    Table 16. Global Top Precision Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2022)

    Table 17. Ranking of Global Top Precision Oncology Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Precision Oncology Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Precision Oncology Product Solution and Service

    Table 21. Date of Enter into Precision Oncology Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Precision Oncology Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Precision Oncology Revenue Market Share by Type (2018-2023)

    Table 25. Global Precision Oncology Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Precision Oncology Revenue Market Share by Type (2024-2029)

    Table 27. Global Precision Oncology Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Precision Oncology Revenue Market Share by Application (2018-2023)

    Table 29. Global Precision Oncology Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Precision Oncology Revenue Market Share by Application (2024-2029)

    Table 31. North America Precision Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Precision Oncology Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Precision Oncology Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Precision Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Precision Oncology Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Precision Oncology Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Precision Oncology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Precision Oncology Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Precision Oncology Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Precision Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Precision Oncology Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Precision Oncology Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Precision Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Precision Oncology Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Precision Oncology Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Acrivon Therapeutics Company Detail

    Table 47. Acrivon Therapeutics Business Overview

    Table 48. Acrivon Therapeutics Precision Oncology Product

    Table 49. Acrivon Therapeutics Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 50. Acrivon Therapeutics Recent Development

    Table 51. Bio-Serv Company Detail

    Table 52. Bio-Serv Business Overview

    Table 53. Bio-Serv Precision Oncology Product

    Table 54. Bio-Serv Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 55. Bio-Serv Recent Development

    Table 56. Exact Sciences Corporation Company Detail

    Table 57. Exact Sciences Corporation Business Overview

    Table 58. Exact Sciences Corporation Precision Oncology Product

    Table 59. Exact Sciences Corporation Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 60. Exact Sciences Corporation Recent Development

    Table 61. Illumina, Inc. Company Detail

    Table 62. Illumina, Inc. Business Overview

    Table 63. Illumina, Inc. Precision Oncology Product

    Table 64. Illumina, Inc. Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 65. Illumina, Inc. Recent Development

    Table 66. Invitae Corporation Company Detail

    Table 67. Invitae Corporation Business Overview

    Table 68. Invitae Corporation Precision Oncology Product

    Table 69. Invitae Corporation Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 70. Invitae Corporation Recent Development

    Table 71. Laboratory Corporation of America Company Detail

    Table 72. Laboratory Corporation of America Business Overview

    Table 73. Laboratory Corporation of America Precision Oncology Product

    Table 74. Laboratory Corporation of America Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 75. Laboratory Corporation of America Recent Development

    Table 76. QIAGEN Company Detail

    Table 77. QIAGEN Business Overview

    Table 78. QIAGEN Precision Oncology Product

    Table 79. QIAGEN Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 80. QIAGEN Recent Development

    Table 81. Rain Oncology Company Detail

    Table 82. Rain Oncology Business Overview

    Table 83. Rain Oncology Precision Oncology Product

    Table 84. Rain Oncology Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 85. Rain Oncology Recent Development

    Table 86. Relay Therapeutics Company Detail

    Table 87. Relay Therapeutics Business Overview

    Table 88. Relay Therapeutics Precision Oncology Product

    Table 89. Relay Therapeutics Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 90. Relay Therapeutics Recent Development

    Table 91. Strata Oncology, Inc. Company Detail

    Table 92. Strata Oncology, Inc. Business Overview

    Table 93. Strata Oncology, Inc. Precision Oncology Product

    Table 94. Strata Oncology, Inc. Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 95. Strata Oncology, Inc. Recent Development

    Table 96. Thermo Fisher Scientific Inc. Company Detail

    Table 97. Thermo Fisher Scientific Inc. Business Overview

    Table 98. Thermo Fisher Scientific Inc. Precision Oncology Product

    Table 99. Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 100. Thermo Fisher Scientific Inc. Recent Development

    Table 101. Variantyx, Inc. Company Detail

    Table 102. Variantyx, Inc. Business Overview

    Table 103. Variantyx, Inc. Precision Oncology Product

    Table 104. Variantyx, Inc. Revenue in Precision Oncology Business (2018-2023) & (US$ Million)

    Table 105. Variantyx, Inc. Recent Development

    Table 106. Research Programs/Design for This Report

    Table 107. Key Data Information from Secondary Sources

    Table 108. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Precision Oncology Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Precision Oncology Market Share by Type: 2022 VS 2029

    Figure 3. Diagnostics Features

    Figure 4. Therapeutics Features

    Figure 5. Global Precision Oncology Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Precision Oncology Market Share by Application: 2022 VS 2029

    Figure 7. Pharmaceutical & Biotechnology Companies Case Studies

    Figure 8. Hospitals & Diagnostic Laboratories Case Studies

    Figure 9. Healthcare Data Companies Case Studies

    Figure 10. Precision Oncology Report Years Considered

    Figure 11. Global Precision Oncology Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Precision Oncology Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Precision Oncology Market Share by Region: 2022 VS 2029

    Figure 14. Global Precision Oncology Market Share by Players in 2022

    Figure 15. Global Top Precision Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Precision Oncology Revenue in 2022

    Figure 17. North America Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Precision Oncology Market Share by Country (2018-2029)

    Figure 19. United States Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Precision Oncology Market Share by Country (2018-2029)

    Figure 23. Germany Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Precision Oncology Market Share by Region (2018-2029)

    Figure 31. China Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Precision Oncology Market Share by Country (2018-2029)

    Figure 39. Mexico Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Precision Oncology Market Share by Country (2018-2029)

    Figure 43. Turkey Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Precision Oncology Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Acrivon Therapeutics Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 46. Bio-Serv Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 47. Exact Sciences Corporation Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 48. Illumina, Inc. Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 49. Invitae Corporation Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 50. Laboratory Corporation of America Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 51. QIAGEN Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 52. Rain Oncology Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 53. Relay Therapeutics Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 54. Strata Oncology, Inc. Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 55. Thermo Fisher Scientific Inc. Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 56. Variantyx, Inc. Revenue Growth Rate in Precision Oncology Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed